These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 9893348)
1. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Dvorak HF; Nagy JA; Feng D; Brown LF; Dvorak AM Curr Top Microbiol Immunol; 1999; 237():97-132. PubMed ID: 9893348 [TBL] [Abstract][Full Text] [Related]
2. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF EXS; 1997; 79():233-69. PubMed ID: 9002222 [TBL] [Abstract][Full Text] [Related]
3. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Dvorak HF; Brown LF; Detmar M; Dvorak AM Am J Pathol; 1995 May; 146(5):1029-39. PubMed ID: 7538264 [TBL] [Abstract][Full Text] [Related]
4. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. Feng D; Nagy JA; Hipp J; Dvorak HF; Dvorak AM J Exp Med; 1996 May; 183(5):1981-6. PubMed ID: 8642308 [TBL] [Abstract][Full Text] [Related]
5. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
6. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Basu S; Nagy JA; Pal S; Vasile E; Eckelhoefer IA; Bliss VS; Manseau EJ; Dasgupta PS; Dvorak HF; Mukhopadhyay D Nat Med; 2001 May; 7(5):569-74. PubMed ID: 11329058 [TBL] [Abstract][Full Text] [Related]
8. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Feng D; Nagy JA; Pyne K; Hammel I; Dvorak HF; Dvorak AM Microcirculation; 1999 Mar; 6(1):23-44. PubMed ID: 10100187 [TBL] [Abstract][Full Text] [Related]
9. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade. Pal S; Iruela-Arispe ML; Harvey VS; Zeng H; Nagy JA; Dvorak HF; Mukhopadhyay D Microvasc Res; 2000 Sep; 60(2):112-20. PubMed ID: 10964585 [TBL] [Abstract][Full Text] [Related]
10. Vascular permeability factor (VPF, VEGF) in tumor biology. Senger DR; Van de Water L; Brown LF; Nagy JA; Yeo KT; Yeo TK; Berse B; Jackman RW; Dvorak AM; Dvorak HF Cancer Metastasis Rev; 1993 Sep; 12(3-4):303-24. PubMed ID: 8281615 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. Brown LF; Olbricht SM; Berse B; Jackman RW; Matsueda G; Tognazzi KA; Manseau EJ; Dvorak HF; Van de Water L J Immunol; 1995 Mar; 154(6):2801-7. PubMed ID: 7876550 [TBL] [Abstract][Full Text] [Related]
12. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Brown LF; Tognazzi K; Dvorak HF; Harrist TJ Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848 [TBL] [Abstract][Full Text] [Related]
13. Biological properties of VEGF/VPF receptors. Terman BI; Dougher-Vermazen M Cancer Metastasis Rev; 1996 Jun; 15(2):159-63. PubMed ID: 8842487 [No Abstract] [Full Text] [Related]
14. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. Feng D; Nagy JA; Brekken RA; Pettersson A; Manseau EJ; Pyne K; Mulligan R; Thorpe PE; Dvorak HF; Dvorak AM J Histochem Cytochem; 2000 Apr; 48(4):545-56. PubMed ID: 10727296 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. Detmar M; Brown LF; Berse B; Jackman RW; Elicker BM; Dvorak HF; Claffey KP J Invest Dermatol; 1997 Mar; 108(3):263-8. PubMed ID: 9036922 [TBL] [Abstract][Full Text] [Related]
16. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. Qu-Hong ; Nagy JA; Senger DR; Dvorak HF; Dvorak AM J Histochem Cytochem; 1995 Apr; 43(4):381-9. PubMed ID: 7534783 [TBL] [Abstract][Full Text] [Related]
17. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Dvorak HF; Detmar M; Claffey KP; Nagy JA; van de Water L; Senger DR Int Arch Allergy Immunol; 1995; 107(1-3):233-5. PubMed ID: 7542074 [TBL] [Abstract][Full Text] [Related]